Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of...
Vous n'êtes pas connecté
Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of cancer vaccines that take advantage of bacteria’s natural tumour-targeting properties. These microbial cancer vaccines can be personalised to attack each individual’s primary tumour and metastases, and may even prevent future recurrences. In [...]
Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of...
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and effectiveness of...
Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and effectiveness of...
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumours use to cripple immune cells and impede their attack—blocking the...
Immunotherapies that mobilise a patient’s immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell...
A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92...
A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92...
Ludwig Cancer Research scientists have devised new types of chimaeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be...
Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of tumour is still...